Reports and Payment. Commencing with the First Commercial Sale of a Licensed Product, COMPANY will deliver to MAYO on or before the following dates: 1 August, a written report setting forth a full accounting showing how any amounts due to MAYO for the preceding calendar year have been calculated as provided in this Agreement, including an accounting of total Net Sales with a reporting of any applicable foreign exchange rates, deductions, allowances, and charges and any payments due from Sublicensees. Each report will include product names, part numbers and quantity sold for each country in which the Licensed Product was sold. Furthermore, the report will include detailed information about Licensed Products sold to MAYO or MAYO Affiliates at cost, pursuant to Section 3.04 (Earned Royalties) or 3.07 ([***]). If no Licensed Product transfers have occurred and no other amounts are due to MAYO, COMPANY will submit a report so stating. Each such report will be accompanied by the payment of all amounts due for such calendar year.
Appears in 3 contracts
Samples: Patent License Agreement (Evelo Biosciences, Inc.), Patent License Agreement (Evelo Biosciences, Inc.), Patent License Agreement (Evelo Biosciences, Inc.)
Reports and Payment. Commencing with the First Commercial Sale of a Licensed Product, COMPANY will deliver to MAYO on or before the following dates: 1 15 February and 15 August, a written report setting forth a full accounting showing how any amounts due to MAYO for the preceding calendar half-year have been calculated as provided in this Agreement, including [***]an accounting of total Net Sales and Sublicense Income with a reporting of any applicable foreign exchange rates, deductions, allowances, and charges and any payments due from Sublicensees. Each report will include product names, part numbers numbers, and quantity sold for each country in which the Licensed Product was sold. Furthermore, the report will include detailed [***] information about Licensed Products sold to MAYO or MAYO Affiliates at costAffiliates, pursuant to Section 3.04 3.03 (Earned Royalties) or 3.07 ([***]). If no Licensed Product transfers have occurred and no other amounts are due to MAYO, COMPANY will submit a report so stating. Each such report will be accompanied by the payment of all amounts due for such calendar yearreporting period. All correspondence from COMPANY pursuant to this Section must include the following e-mail address: [***].
Appears in 1 contract
Samples: Patent License Agreement (Perspective Therapeutics, Inc.)